A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/1992
12/01/1992	WO1992021331A1 Pharmaceutical carrier
12/01/1992	US5168102 Endocrine manipulation to improve body composition of poultry
12/01/1992	US5168053 Ribonuclease and genetically-engineered external guide sequence of nucleotides as treatment for AIDS
12/01/1992	US5167956 Immunotoxin with in-vivo t cell suppressant activity
12/01/1992	US5167947 Enhancement of absorption of radioprotective drugs
12/01/1992	CA2069678A1 Process for the preparation of polyethylene oxide of medium molecular weight
12/01/1992	CA1311086C Chimeric peptides for neuropeptide delivery through the blood-brain barrier
12/01/1992	CA1310882C Composition based on diorganopolysiloxane gum containing iodine, for water processing
11/1992
11/29/1992	WO1992021328A1 Chewable drug-delivery composition
11/29/1992	CA2069650A1 Hydrogel and method of producing same
11/26/1992	WO1992020823A1 Backbone modified oligonucleotide analogs
11/26/1992	WO1992020822A1 Backbone modified oligonucleotide analogues
11/26/1992	WO1992020701A2 Interleukin receptor targeted molecules for treatment of accelerated atherosclerosis
11/26/1992	WO1992020647A1 Lipoaminoacids, preparation method and applications
11/26/1992	WO1992020377A1 Skin permeation enhancer compositions using glycerol monolinoleate
11/26/1992	WO1992020376A1 Percutaneous absorption promoter composition and external preparation for percutaneous administration
11/26/1992	WO1992020375A1 Non-stinging measles-mumps-rubella vaccine composition
11/26/1992	WO1992020371A1 Targeted delivery of bone growth factors
11/26/1992	WO1992020349A1 Water insoluble derivatives of polyanionic polysaccharides
11/26/1992	WO1992020343A1 Suppression of thromboxane levels by percutaneous administration of aspirin
11/26/1992	WO1992020326A1 Multi-layered controlled release formulation
11/26/1992	WO1992020324A1 Polyurethane hydrogel compositions for iontophoretic drug delivery
11/26/1992	WO1992020316A2 Targeted delivery of genes encoding immunogenic proteins
11/26/1992	CA2109599A1 Lipopolyaminoacids, preparation and uses thereof
11/26/1992	CA2103378A1 Backbone modified oligonucleotide analogues
11/26/1992	CA2103064A1 Targeted delivery of genes encoding immunogenic proteins
11/25/1992	EP0515312A2 Pharmaceutical composition containing terbinafine as an anti-mycotic agent
11/25/1992	EP0515310A1 Topical composition of terbinafine
11/25/1992	EP0514967A1 Low solubility drug-coated bead compositions
11/25/1992	EP0514814A1 Diltiazem formulation
11/25/1992	EP0514794A1 Plaster preparation
11/25/1992	EP0514711A1 Buffered matrix aspirin tablet
11/25/1992	EP0514523A1 Method for making liposomes of enhanced entrapping capacity toward foreign substances to be encapsulated.
11/25/1992	EP0514435A1 Alcoholic aqueous gel-type phospholipid composition, its use and topical preparations containing it.
11/25/1992	EP0514406A1 Article for the controlled delivery of an active substance, comprising a hollow space fully enclosed by a wall and filled in full or in part with one or more active substances.
11/25/1992	EP0163696B1 Use of a bioadhesive
11/25/1992	CA2068762A1 Plaster preparation
11/24/1992	US5166331 Antibiotics, viricides, antiinflammatory agents, wound healing agents, cytostatics, anesthetics, cholinergics or adrenergics
11/24/1992	US5166322 Cysteine added variants of interleukin-3 and chemical modifications thereof
11/24/1992	US5166320 Carrier system and method for the introduction of genes into mammalian cells
11/24/1992	US5166319 Interfacial condensation of bioactive compounds and the site-specific compounds and conjugates thereof
11/24/1992	US5166315 Sequence-specific binding polymers for duplex nucleic acids
11/24/1992	US5166194 Transdermally applicable pharmaceutical preparations having a pharmaceutically usable glycoside content
11/24/1992	US5165938 Topical treatment with cells
11/24/1992	US5165937 Controlled release tablets containing flavoxate
11/24/1992	US5165923 Methods and compositions for the treatment of hodgkin's disease
11/24/1992	US5165922 Treatment of breast cancer
11/24/1992	US5165921 Skin disorders or viricides
11/24/1992	CA1310584C Spheroids
11/22/1992	CA2103464A1 Backbone modified oligonucleotide analogs
11/21/1992	WO1992020699A1 Steroid compound combined with polysaccharide
11/21/1992	WO1992020355A1 Method and composition for treating acne vulgaris containing a substantially anhydrous complex of pvp-h2o¿2?
11/21/1992	CA2107673A1 Method and composition for treating acne vulgaris containing a substantially anhydrous complex of pvp-h2o2
11/21/1992	CA2087452A1 Steriod compound combined with polysaccharide
11/21/1992	CA2068980A1 Diltiazem formulation
11/19/1992	EP0514208A1 Non-stinging measles-mump-rubella vaccine composition
11/19/1992	EP0514008A1 Pharmaceutical preparations based on gastrointestinal mucosa-adherent matrixes or coatings
11/19/1992	EP0513878A2 Pharmaceutical compositions containing cationic surfactants
11/19/1992	EP0513832A1 Use of dibutyl adipate and isopropyl myristate in topical and transdermal products
11/19/1992	EP0513778A2 Hybrid monoclonal antibodies and compositions containing them
11/19/1992	EP0513388A1 Peptide with activity of inhibiting cancer cell infiltration, composite thereof, and cancer metastasis inhibitor
11/19/1992	EP0513332A1 Conjugates of poly(vinylsaccharide) with proteins for the stabilization of proteins
11/19/1992	EP0513099A1 Novel vehicle gases and their use in medical preparations
11/19/1992	EP0192660B1 Absorption enhancing agents
11/19/1992	DE4116123A1 Skin diseases treatment agent - contains 2-hydroxy-5-methyl-lauro-phenone oxime combined with natural hydrating agents, moisturisers and/or penetration promoters
11/19/1992	DE4115849A1 Penetrationsfoerdernde substanz Penetrationsfoerdernde substance
11/18/1992	WO1992020364A1 Cytokine receptor targeted molecules for treatment of meoplastic cell growth
11/18/1992	CN1066184A Optimized tablet formulation
11/18/1992	CN1066183A Convertible microemulsion formulations
11/18/1992	CA2103258A1 Cytokine receptor targeted molecules for treatment of neoplastic cell growth
11/18/1992	CA2068813A1 Hybrid monoclonal antibodies and compositions containing them
11/18/1992	CA2068742A1 Non-stinging vaccine composition
11/17/1992	US5164488 Formation of liposome dispersion
11/17/1992	US5164416 Improved absorption
11/17/1992	US5164406 Method for enhancing transdermal penetration and compositions useful therein
11/17/1992	US5164405 Cardiovascular
11/17/1992	US5164380 Improved solubility and pharmacokinetic properties
11/17/1992	US5164379 Sucralfate/cyclodextrin complexes
11/17/1992	US5164192 Effervescent composition for oral rehydration
11/17/1992	US5164189 Single layer transdermal drug administration system
11/17/1992	US5164188 Biodegradable ocular implants
11/17/1992	CA2067314A1 Low solubility drug-coated bead compositions thereof
11/17/1992	CA1310272C Ibuprofen sustained release matrix and process
11/17/1992	CA1310270C Pharmaceutical preparation for percutaneous administration containing eperisone or tolperisone or salt thereof
11/17/1992	CA1310264C Modified antibodies for enhanced clearance
11/16/1992	WO1992020378A1 Penetration-promoting substance
11/14/1992	CA2042152A1 Additive for irrigation solution or surgical solution
11/12/1992	WO1992019973A1 Novel antibodies, and methods for their use
11/12/1992	WO1992019646A1 Analog of endothelial leukocyte adhesion molecule (elam)
11/12/1992	WO1992019281A2 New conjugates, consisting of a glycoprotein and a nucleic acid-binding substance
11/12/1992	WO1992019276A1 Dermatologic ointment
11/12/1992	WO1992019271A1 Percutaneous administration and absorption promoter composition and external preparation for percutaneous administration
11/12/1992	WO1992019264A1 Biomodulators as universal imaging agents
11/12/1992	WO1992019260A1 Peptide hormone solution
11/12/1992	WO1992019257A1 Compositons for the treatment of chronic fatigue syndrome
11/12/1992	WO1992019242A1 Free amine benzophenanthridine alkaloid compositions
11/12/1992	WO1992019233A2 Sustained release composition and methods of use thereof
11/12/1992	WO1992019228A1 Optimized tablet formulation
11/12/1992	WO1992019227A2 Pharmaceutical formulations
11/12/1992	WO1992019213A2 Enhancement of abnormal tissue uptake of antibodies, tumor-specific agents or conjugates thereof for diagnostic imaging or therapy

1 ... 1605 1606 1607 1608 1609 1610 1611 1612 1613 1614 1615 1616 1617 1618 1619 1620 1621 1622 1623 1624 1625 ... 1712